Agilent Technologies Inc.

Solid Q1 Performance: Agilent reported Q1 revenue of $1.681 billion, a 1% increase year-over-year (YOY), exceeding expectations. Core revenue growth was 1.2%, with additional adjustments indicating up to 3% growth excluding Lunar New Year impacts. Earnings per share (EPS) were $1.31, reflecting a 2% YOY increase.

Guidance and Outlook: For the full fiscal year 2025, Agilent is maintaining its core revenue growth guidance of 2.5% to 3.5%. However, they are adjusting full-year reported revenue to $6.68 billion to $6.76 billion due to increased currency headwinds, which are now expected to impact revenue by 1.9%. Q2 revenue guidance is set at $1.61 billion to $1.65 billion, indicating a modest expected growth of 2.5% to 5% on a core basis.

Impact of Inflation and NI Funding Concerns: Risks around potential reductions to National Institutes of Health (NIH) funding, representing less than 1% of revenue, are being monitored but are not presently seen as a significant risk to overall business performance. Additionally, tariffs and inflation are being tracked, but mitigation strategies are in place.